ForumIAS LATEST
- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
- India has indigenously developed the first ever vaccine to treat bloody dysentery known as Shigellosis.Shigellosis is an infectious disease caused by a group of bacteria called Shigella.
- The vaccine has been developed by Indian Council of Medical Research (ICMR) and the National Institute of Cholera and Enteric Diseases (NICED).
- Most of those who are infected with Shigella develop diarrhoea,fever and stomach cramps starting a day or two after they are exposed to the bacteria.Shigellosis is recognised as a disease mainly affecting Asian and African nations.
- Further,the disease is currently treated through antibiotics but considering the fact that antibiotic resistance has become a major concern,the vaccine was the need of the hour.
- The developed vaccine is a dead vaccine which means it is a dead germ of the bacteria causing disease which would be introduced in the body so that the immune system develops immunity against it.
